Literature DB >> 14625026

Change in the expression of c-fos in the rat brain following sciatic nerve ligation.

Minoru Narita1, Satoru Ozaki, Michiko Narita, Yuya Ise, Yoshinori Yajima, Tsutomu Suzuki.   

Abstract

A little or none is known about the direct evidence for the possible change in the expression of c-fos at the supraspinal level after nerve injury. Therefore, the present study was designed to investigate the level of c-fos in some brain regions following sciatic nerve ligation in the rat. Immunoblot analysis clearly showed that the levels of c-fos in the rat frontal cortex, thalamus and periaqueductal gray matter were significantly increased, whereas it was significantly decreased in the nucleus accumbens and ventral tegmental area. Under these conditions, the levels of c-fos in the rat amygdala, hippocampus and hypothalamus were not changed. These results provide direct evidence that the neuropathic pain-like state causes a substantial change in the expression of c-fos in the rat brain.

Entities:  

Mesh:

Year:  2003        PMID: 14625026     DOI: 10.1016/j.neulet.2003.08.052

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

Review 1.  The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward?

Authors:  Patrick H Finan; Bethany Remeniuk; Kelly E Dunn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-01       Impact factor: 5.067

2.  Spatiotemporal pattern of concurrent spinal and supraspinal NF-κB expression after peripheral nerve injury.

Authors:  Chiu-Wen Chou; Gordon T C Wong; Grewo Lim; Shuxing Wang; Michael G Irwin; Jianren Mao
Journal:  J Pain       Date:  2010-05-26       Impact factor: 5.820

3.  The role of the thalamus in modulating pain.

Authors:  Che Badariah Ab Aziz; Asma Hayati Ahmad
Journal:  Malays J Med Sci       Date:  2006-07

4.  Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.

Authors:  Harshini Neelakantan; Sara Jane Ward; Ellen Ann Walker
Journal:  Exp Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.157

5.  Paeoniflorin exerts analgesic and hypnotic effects via adenosine A1 receptors in a mouse neuropathic pain model.

Authors:  Dou Yin; Yuan-Yuan Liu; Tian-Xiao Wang; Zhen-Zhen Hu; Wei-Min Qu; Jiang-Fan Chen; Neng-Neng Cheng; Zhi-Li Huang
Journal:  Psychopharmacology (Berl)       Date:  2015-10-29       Impact factor: 4.530

6.  Involvement of the lateral amygdala in the antiallodynic and reinforcing effects of heroin in rats after peripheral nerve injury.

Authors:  Thomas J Martin; Nancy L Buechler; Susy A Kim; Eric E Ewan; Ruoyu Xiao; Steven R Childers
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

7.  Assessment of Behavioral Disruption in Rats with Abdominal Inflammation Using Visual Cue Titration and the Five-choice Serial-reaction Time Task.

Authors:  Thomas J Martin; Tracy J Strassburg; Amanda L Grigg; Susy A Kim; Douglas G Ririe; James C Eisenach
Journal:  Anesthesiology       Date:  2017-08       Impact factor: 7.892

8.  LncRNA H19 secreted by umbilical cord blood mesenchymal stem cells through microRNA-29a-3p/FOS axis for central sensitization of pain in advanced osteoarthritis.

Authors:  Qinyan Yang; Yutong Yao; Daqiang Zhao; Haibo Zou; Chunyou Lai; Guangming Xiang; Guan Wang; Le Luo; Ying Shi; Yan Li; Maozhu Yang; Xiaolun Huang
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

9.  Nerve injury-induced tactile allodynia is present in the absence of FOS labeling in retrogradely labeled post-synaptic dorsal column neurons.

Authors:  En-Tan Zhang; Michael H Ossipov; Dong-Qin Zhang; Josephine Lai; Frank Porreca
Journal:  Pain       Date:  2006-12-06       Impact factor: 6.961

Review 10.  Chronic pain alters drug self-administration: implications for addiction and pain mechanisms.

Authors:  Thomas J Martin; Eric Ewan
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.